Results 211 to 220 of about 98,351 (302)
Progress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment. [PDF]
Qin H +6 more
europepmc +1 more source
Abstract Purpose The present study aimed to compare the efficacy and safety of a combined injection of stromal vascular fraction (SVF) and platelet rich plasma (PRP) versus a high molecular weight (HMW) hyaluronic acid (HA) injection in patients with knee osteoarthritis (KOA).
Trifon Totlis +6 more
wiley +1 more source
Effect of platelet-rich plasma on peri-implant bone repair. [PDF]
Jalaluddin M +6 more
europepmc +1 more source
Abstract Purpose To evaluate the safety and efficacy of intra‐articular autologous transplantation of adipose‐derived connective tissue micrografts rich in stromal vascular fraction (CTM‐SVF), obtained using an enzyme‐free system (Hy‐Tissue® SVF) for knee osteoarthritis (OA). Methods Thirty patients (mean age of 53.3 ± 6.4 years) with Kellgren–Lawrence
Laura Mangiavini +11 more
wiley +1 more source
Clinical Evaluation of Autologous PRP (Platelet-Rich Plasma) in the Treatment of Periodontitis in Small-Breed Dogs. [PDF]
Kvitka D +5 more
europepmc +1 more source
Platelet-rich plasma injections.
Danielle, Perry +2 more
openaire +1 more source
Abstract Purpose To evaluate the failure rates of all‐inside meniscal repair based on tear morphology in stable knees (i.e., without concomitant anterior cruciate ligament reconstruction [ACLR]) and to assess the influence of failure. Methods This retrospective cohort study included 1008 patients who underwent arthroscopic all‐inside meniscal repair ...
Christoffer von Essen +3 more
wiley +1 more source
Intralesional Platelet-Rich Plasma Injection in Patients with Recalcitrant Alopecia Areata. [PDF]
Aydogan M +2 more
europepmc +1 more source
Abstract Purpose The aim was to compare the safety profiles of corticosteroids (CS), hyaluronic acid (HA), blood‐derived products based on platelet concentrates (for simplicity indicated as PRP ‐ platelet‐rich plasma ‐ being PRP the most common product), and cell‐based therapies (namely products exploiting the therapeutic function of mesenchymal ...
Alessandro Bensa +8 more
wiley +1 more source

